| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.21 | 2e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.2 | 4e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.23 | 9e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |